We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Fulcrum Therapeutics
FULC
$288M
| $236K | ﹤0.01% |
22,475
+10,120
| +82% | +$102K |
|
|
AMPE
2877
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $235K | ﹤0.01% |
+470
| New | +$252K |
|
2878
Treace Medical Concepts
TMCI
$284M
| $234K | ﹤0.01% |
+7,480
| New | +$238K |
|
|
DS
2879
DELISTED
Drive Shack Inc.
DS
| $234K | ﹤0.01% |
+70,685
| New | +$226K |
|
2880
Alta Equipment Group
ALTG
$240M
| $233K | ﹤0.01% |
17,558
-2,245
| -11% | -$30.7K |
|
2881
Finance of America Companies
FOA
$197M
| $233K | ﹤0.01% |
+3,057
| New | +$296K |
|
2882
LiveOne
LVO
$56.9M
| $233K | ﹤0.01% |
4,933
-1,442
| -23% | -$62.6K |
|
|
PZN
2883
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $233K | ﹤0.01% |
21,192
-1,081
| -5% | -$11.9K |
|
2884
Tilray
TLRY
$605M
| $232K | ﹤0.01% |
+1,284
| New | +$225K |
|
|
FTSI
2885
DELISTED
FTS International, Inc. Common Stock
FTSI
| $231K | ﹤0.01% |
+8,178
| New | +$212K |
|
2886
Centrus Energy
LEU
$3.5B
| $230K | ﹤0.01% |
+9,047
| New | +$216K |
|
2887
4D Molecular Therapeutics
FDMT
$552M
| $229K | ﹤0.01% |
9,507
+3,651
| +62% | +$112K |
|
2888
Wave Life Sciences
WVE
$1.19B
| $229K | ﹤0.01% |
34,380
+3,865
| +13% | +$25.3K |
|
2889
Apyx Medical
APYX
$175M
| $228K | ﹤0.01% |
22,092
-17,970
| -45% | -$178K |
|
2890
Credicorp
BAP
$31.2B
| $228K | ﹤0.01% |
+1,884
| New | +$246K |
|
|
LUNA
2891
DELISTED
Luna Innovations Incorporated
LUNA
| $228K | ﹤0.01% |
21,090
-980
| -4% | -$10.7K |
|
2892
ClearPoint Neuro
CLPT
$408M
| $227K | ﹤0.01% |
+11,904
| New | +$230K |
|
2893
Algonquin Power & Utilities
AQN
$4.43B
| $226K | ﹤0.01% |
15,212
| – | – |
|
2894
InfuSystem Holdings
INFU
$236M
| $223K | ﹤0.01% |
10,705
+478
| +5% | +$9.66K |
|
2895
Universal Logistics Holdings
ULH
$485M
| $221K | ﹤0.01% |
9,480
-1,145
| -11% | -$28.5K |
|
2896
Concrete Pumping Holdings
BBCP
$488M
| $220K | ﹤0.01% |
25,964
-3,310
| -11% | -$26.5K |
|
2897
Biglari Holdings Class B
BH
$1.22B
| $220K | ﹤0.01% |
1,381
-260
| -16% | -$40K |
|
2898
Capital Bancorp
CBNK
$616M
| $219K | ﹤0.01% |
10,720
-1,261
| -11% | -$26.9K |
|
2899
Identive
INVE
$61.2M
| $219K | ﹤0.01% |
+12,868
| New | +$194K |
|
2900
Aterian
ATER
$5.02M
| $218K | ﹤0.01% |
+1,243
| New | +$291K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.